)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Kamada (KMDA) investor relations material
Kamada H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H.C. Wainwright 27th Annual Global Investment Conference summary8 Sep, 2025
Opening remarks and company overview
Conference opened with a welcome and introduction of the CEO of a global biopharmaceutical company specializing in specialty plasma therapeutics.
Company operates in a niche plasma products market, with annual sales between $178 million and $190 million and EBITDA margins improving to over 20%.
Vertically integrated strategy includes plasma collection, product development, and global distribution.
Financial performance and growth
Cash positive and profitable, with $66 million in cash and consistent EBITDA growth.
Revenue and EBITDA have grown significantly, with annual per share growth of 58% and adjusted EBITDA rising from $16.6 million to $22.5 million.
On track to meet annual guidance, with strong performance in the first half of the year.
Product portfolio and innovation
Six specialty plasma products, including first-to-market anti-COVID antibodies and pediatric antibody trials.
Key products include Kedrab (rabies immunoglobulin) with 50% U.S. market share and CytoGam for transplantation, both with global reach.
Ongoing expansion into biosimilars, with multiple launches planned through 2026.
How does FDA's P-value impact inhaled AAT study?
What is the current scope of Kamada's M&A search?
What is the expected revenue from new plasma centers?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Kamada earnings date
Q3 202512 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Kamada Ltd. is a globall biopharmaceutical company that focuses on the development, production, and marketing of plasma-derived protein therapeutics. The company is known for its specialty in products designed for rare diseases, operating across two main segments: Proprietary Products and Distribution. Kamada's diverse product range includes treatments for conditions such as immune thrombocytopenic purpura, hepatitis B, varicella, and Alpha-1 Antitrypsin Deficiency (AATD), among others. Additionally, it has developed specific immunoglobulins for various applications, including rabies and diseases caused by Rh-negative in the fetus. Kamada markets its products through strategic partnerships and distributors internationally, including collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. The company prides itself on its industry-leading manufacturing capabilities and a robust development pipeline aimed at addressing unmet medical needs. Kamada Ltd. is headquartered in Rehovot, Israel, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage